ID   ONCM_RAT                Reviewed;         239 AA.
AC   Q65Z15;
DT   31-MAY-2011, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2004, sequence version 1.
DT   29-MAY-2024, entry version 121.
DE   RecName: Full=Oncostatin-M;
DE            Short=OSM;
DE   Flags: Precursor;
GN   Name=Osm;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15743783; DOI=10.1016/s0002-9440(10)62292-4;
RA   Okaya A., Kitanaka J., Kitanaka N., Satake M., Kim Y., Terada K.,
RA   Sugiyama T., Takemura M., Fujimoto J., Terada N., Miyajima A.,
RA   Tsujimura T.;
RT   "Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing
RT   differentiation into hepatocytes.";
RL   Am. J. Pathol. 166:709-719(2005).
CC   -!- FUNCTION: Growth regulator. Inhibits the proliferation of a number of
CC       tumor cell lines. It regulates cytokine production, including IL-6, G-
CC       CSF and GM-CSF from endothelial cells (By similarity). Uses only type
CC       II OSM receptor (heterodimers composed of OSMR and IL6ST). Involved in
CC       the maturation of fetal hepatocytes, thereby promoting liver
CC       development and regeneration. {ECO:0000250,
CC       ECO:0000269|PubMed:15743783}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed at higher levels in
CC       liver, skin and spleen. {ECO:0000269|PubMed:15743783}.
CC   -!- PTM: Propeptide processing is not important for receptor binding
CC       activity but may be important growth-inhibitory activity.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the LIF/OSM family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB167521; BAD44757.1; -; mRNA.
DR   RefSeq; NP_001006962.1; NM_001006961.1.
DR   AlphaFoldDB; Q65Z15; -.
DR   SMR; Q65Z15; -.
DR   STRING; 10116.ENSRNOP00000032548; -.
DR   PhosphoSitePlus; Q65Z15; -.
DR   PaxDb; 10116-ENSRNOP00000032548; -.
DR   Ensembl; ENSRNOT00000035591.4; ENSRNOP00000032548.2; ENSRNOG00000024390.4.
DR   Ensembl; ENSRNOT00055052053; ENSRNOP00055042989; ENSRNOG00055030023.
DR   Ensembl; ENSRNOT00060047045; ENSRNOP00060039128; ENSRNOG00060027122.
DR   Ensembl; ENSRNOT00065051649; ENSRNOP00065042522; ENSRNOG00065029899.
DR   GeneID; 289747; -.
DR   KEGG; rno:289747; -.
DR   UCSC; RGD:1585012; rat.
DR   AGR; RGD:1585012; -.
DR   CTD; 5008; -.
DR   RGD; 1585012; Osm.
DR   eggNOG; ENOG502RVJA; Eukaryota.
DR   GeneTree; ENSGT00390000004850; -.
DR   HOGENOM; CLU_102028_0_0_1; -.
DR   InParanoid; Q65Z15; -.
DR   OMA; FMHSVGQ; -.
DR   OrthoDB; 4641001at2759; -.
DR   PhylomeDB; Q65Z15; -.
DR   TreeFam; TF338204; -.
DR   Reactome; R-RNO-6788467; IL-6-type cytokine receptor ligand interactions.
DR   PRO; PR:Q65Z15; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000024390; Expressed in thymus and 5 other cell types or tissues.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW.
DR   GO; GO:0005125; F:cytokine activity; ISO:RGD.
DR   GO; GO:0008083; F:growth factor activity; ISO:RGD.
DR   GO; GO:0005147; F:oncostatin-M receptor binding; ISO:RGD.
DR   GO; GO:0048266; P:behavioral response to pain; ISO:RGD.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0140013; P:meiotic nuclear division; ISO:RGD.
DR   GO; GO:0046888; P:negative regulation of hormone secretion; ISO:RGD.
DR   GO; GO:0045835; P:negative regulation of meiotic nuclear division; ISO:RGD.
DR   GO; GO:0038165; P:oncostatin-M-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0007422; P:peripheral nervous system development; ISO:RGD.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISO:RGD.
DR   GO; GO:0009408; P:response to heat; ISO:RGD.
DR   Gene3D; 1.20.1250.10; -; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR001581; Leukemia_IF/oncostatin.
DR   InterPro; IPR019827; Leukemia_IF/oncostatin_CS.
DR   InterPro; IPR039578; OSM.
DR   PANTHER; PTHR14261; ONCOSTATIN M; 1.
DR   PANTHER; PTHR14261:SF0; ONCOSTATIN-M; 1.
DR   Pfam; PF01291; LIF_OSM; 1.
DR   SMART; SM00080; LIF_OSM; 1.
DR   SUPFAM; SSF47266; 4-helical cytokines; 1.
DR   PROSITE; PS00590; LIF_OSM; 1.
PE   2: Evidence at transcript level;
KW   Cleavage on pair of basic residues; Cytokine; Disulfide bond;
KW   Growth regulation; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..208
FT                   /note="Oncostatin-M"
FT                   /evidence="ECO:0000250|UniProtKB:P13725"
FT                   /id="PRO_0000408765"
FT   PROPEP          209..239
FT                   /evidence="ECO:0000250|UniProtKB:P13725"
FT                   /id="PRO_0000408766"
FT   DISULFID        29..140
FT                   /evidence="ECO:0000250"
FT   DISULFID        72..179
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   239 AA;  27106 MW;  78BC63B25A148B16 CRC64;
     MRAQPPPRTL LSLALALLFL SMSWAKRGCS SSSPKLLSQL KSQANITGNT ASLLEPYILH
     QNLNTLTLRA ACTEHPVAFP SEDMLRQLSK PDFLSTVHAT LGRVWHQLGA FRQQFPKIQD
     FPELERARQN IQGIRNNVYC MARLLHPPLE IPEPTQADSG TSRPTTTAPG IFQIKIDSCR
     FLWGYHRFMG SVGRVFEEWG DGSRRSRRHS PLWAWLKGDH RIRPSRSSQS AMLRSLVPR
//
